University of Maryland Francis King Carey School of Law

DigitalCommons@UM Carey Law
Faculty Scholarship

Francis King Carey School of Law Faculty

3-1-2003

Achieving the Right Balance in Oversight of Physician Opioid
Prescribing for Pain: The Role of State Medical Boards
Diane E. Hoffmann
University of Maryland School of Law, dhoffmann@law.umaryland.edu

Anita J. Tarzian

Follow this and additional works at: https://digitalcommons.law.umaryland.edu/fac_pubs
Part of the Bioethics and Medical Ethics Commons, and the Health Law and Policy Commons

Digital Commons Citation
Hoffmann, Diane E. and Tarzian, Anita J., "Achieving the Right Balance in Oversight of Physician Opioid
Prescribing for Pain: The Role of State Medical Boards" (2003). Faculty Scholarship. 146.
https://digitalcommons.law.umaryland.edu/fac_pubs/146

This Article is brought to you for free and open access by the Francis King Carey School of Law Faculty at
DigitalCommons@UM Carey Law. It has been accepted for inclusion in Faculty Scholarship by an authorized
administrator of DigitalCommons@UM Carey Law. For more information, please contact
smccarty@law.umaryland.edu.

Achieving the Right Balance in
Oversight of Physician Opioid
Prescribing for Pain: The Role
of State Medical Boards
Diane E. Hoffmann and Anita J. Tarzian

ro prescribe them to any patients bur tho c uffcring from the
most serious pain." 1 This opinion was conveyed by anumber of state medical boards to physicians who were disciplined
for prescribing ourside of these boundaries. The ·'sea change"
came about "a evidence moumed that patients, especially
cancer patients, were being underrreated for their pain, and
that addiction was not a significanr problem for puin patients
with no prior history of substance abuse. "2 ln re ponse, phy..,icians hegan ro prescribe greater amounts of pain medication.
In addition, professional and governmental agencies established clinical guidelines encouraging the appropriate use of
opioids in the treatment of cancer pain. Many stare legislamres al~o passed "intractable pain tamtes." These law "were
designed ro provide physicians with some assurance~> by reducing both the real and perceived risks of being subjected ro
regulatory anctions for treating pain with controlled sub'>tances."'
Yet, ar the same time that these new legal pressures would
<,cem to counteract rhe pressures to underrrcat, a renewed
concern about drug diversion, in light of the abuse associated with OxyContin, has taken shape. Evidence of diver ion
of the medication from legitimate users ro addict'> has caught
the attention of drug and law enforcement agencies that have
linked OxyConrin to overdose deaths, pharmacy robberies,
and other criminal activities related to obraining rhc drug.
This rurn of events has the potential for rekindling the attention of state medical boards and law enforcement agencies
toward ph)'Sician prescribing practices for patienrs suffering
from pain.
In an effort to better tmdersmnd how state medical boards
are evaluating and balancing the need for adequate pain treatment with concerns about drug diver ion and inappropriate
prescribing, we undertook a survey of <,tate medical boards
across the country. This article, after briefl)' describing the
evolution of medical knowledge regarding the treatment of

ncermmry regarding potential disciplinary action may
give phy~ician~ pause when considering whether to
accept a chronic pain patient or how ro treat a p.Itiem who may require long-term or high doses of opioids.
Surveys h..we 'ihown that physicians fear potential disciplinary action for prescribing controlled substances and thar
physicians will, in some cases, inadequately prescribe opioids due to fear of regulatory scrutiny. Prescribing opioids for
long-term pain management, particularly noncancer pain
management, has been comroversial; and boards have inve~
tigated ~md, in some cases, disciplined physicians for such
prescribing. While in virruallr all of these cases the disciplinary action\ were successful!) appealed, news of the success
wa.., nor often as well-publicized as news of the disciplinar}
acnons, le~wing wme physicians confused about their potentialliabilif} when prescribing opioids for pain. The confusion
has perhaps increased as a re ult of two relatively recenr
cases, one where a physician w<U>succcssfully disciplined by
~1 stare medical board for undcrrream1cnt of his patient'>' pain,
and anorher where the physictan was successfully o;ued for
inadequate pain treatment.
In the first case, in September J 999, the Oregon Medical 13oard disciplined a physician for failun: to adequately
n·eat ~cvcral of hi~ pariems for pain. Less than two year~
later, a California physician \Va'> successfully sued for hi..,
undertrearmenr of a patient's pain. These cases reflect a changing attitude toward pai n treatment in the United States- a
recognition that pariems, especially patients ar the end of
life, have a right to adequate pain treatment. This shift in
thinking appear'> to have begun in the late 1980s. Prior ro
this time, "according to established medical opinion, the
likelihood of ,1ddiction w opioids was considered too great
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pain, the history of efforrs to regulate controlled substances
used to treat pain, and the Literature regarding physician concerns about legal repercussions for prescribing opioids,
reports on the results of the survey.
We conclude that boards have made improvements in
the way they approach physicians who prescribe large doses
of opioids. Greater reliance on pain policies has given many
boards clearer criteria for when to investigate and discipline
physicians for opioid prescribing violations. The observed
improvements involve recognition by most boards that physicians have an obligation to provide adequate pain
management to their patients. This recognition has required
boards to balance their concerns about opioid overprescribing with their concerns about pain undertreatment. We found,
however, that boards appear to be more concerned with violation of standard of care in cases of overtreatmem versus
undemeatment. Respondents (spealcing on behalf of their
boards) viewed opioid overprescribing as a dear violation of
standard of care and a clear example of patient harm, whereas
pain undertrea011ent- particularly for nonmalignant chronic
pain -was not so clearly perceived as a standard of care
violation, <md generally required a higher threshold of hann.
We conclude that the boards are still trying to find the right
balance berween promoting adequate pain management and
protecting against opioid diversion and abuse.

and bureaus of narcotics control. Since the 1970s, the
government's attitude has shifted in focus, particularly after
Presidenr Reagan rook office, from viewing drug abuse as a
public health problem ro viewing it as a political, law enforcement, and moral issue? Although the DEA and other
federal laws and policies rend to be less restrictive of physician practices than state laws and enforcement practices,
concerns about Medimre and Medicaid fraud and abuse and
the government's "war on drugs" have put pressure on state
medi.cal boards.8 This has resulted in some state boards disciplining physicians for "overprescribing" opioids, including
physicians who were treating pain patients. 9 Thus, in addition to fears that patients will become addicted, 10 and that
doses of opioids that are roo high will lead to patient deaths, 11
physicians avoid prescribing opioids because they believe
they may face legal or regularory sanctions or simply be the
target of investigation by licensing boards or other law enforcement agencies. 12 However, research has hown that
physicians' fears of legal or regulatory sanctions are more
the result of a "chilling effect" than of the actual risk of
disciplinary or legal liability they face if they properly prescribe opioids for pain management. 11
Several physician surveys have provided evidence of the
chilling effect of sanctions against physicians for opioid prescribing. ln 1990, physician members of the Eastern
Cooperative Oncology Group were surveyed and 18 percent
of 897 responding oncologists rated excessive regulation of
analgesics as one of the top four barriers to adequate cancer
pain management.' 4 Ln a 199 L survey of members of the
American Pain Society, 40 percent of surveyed physician
members said concerns about regulatory scrutiny rather than
medical reasons led them ro avoid prescribing opioids for
chronic noncancer pain patients...1 [n a survey of Wisconsin
physicians c011ducted in the same year, over half reported
decreasing the dose, quantit)) or number of refills, or switching to a lower scheduled medication, due to fear of regulatory
scruriny. 1" And, in a I 993 California survey, 69 percent of
physician respondents felt that doctors were more conservative in their use of opioids in pain management because of
fear of disciplinary action, and a third felt that their own
patients may be suffering from untreated pain. 17
ln an effort ro better understand stare medical board
members' knowledge and attitudes toward physician prescribing of opioids for pain management, the University of
Wisconsin Pain & Policy Studies Group (PPSG) conducted a
survey of members of state medical boards in 1991. Joranson
and colleagues found that ·' [w]hile most respondents agreed
that the prescribing of opioids for the cancer patient was
legal and generally acceptable medical practice, only 12%
were confident in the legality of prescribing for the patient
with chronic non-cancer pain; the majority of respondentS
(77%) would discourage this practice or even investigate it
as a violation of the law." 18 They also found that board members responding to the survey had a lack of knowledge about

THE EvoLUTION OF TREATING PAlN WITH Ortoms

Progress in pain management has evolved over the last few
demdes. Beginning with the hospice movement i.n the 1960s,
and continuing beyond the 1994 guidelines for the management of cancer pain published by the Agency for Health
Care Policy & Research, opioids (in combination with other
medications) have been idenri fied as the standard treatment
for moderate to severe cancer pain. In addition, opioid
therapy has been shown to be effective for patients with certain types of chronic nonmalignant pain, without the
occurrence of intolerable side-effects or the development of
aberrant drug-related behaviors.4 Its use in patients with
malignant and nonmalignant pain bas been shown to improve functional status a11d quality of life. 1 Moreover, the
consensus among addiction specialistS is that substance abuse
history per se does not preclude the use of opioids for pain
management, bur it does mandate careful assessment and
monitoring of such patients by a trained pain specialist. 6
At the same time thar these pain management treatment
standards have evolved, there have been ongoing efforts to
regulate the prescribing of opioids. These efforts began with
the passage in 1970 of the ControUed Substances Act and the
establishment in 1973 of the Drug Enforcement Agency (D EA).
At the federal level, the ConrroUed Substances Act and the
DEA make up the main armarnents in the government's effortS ro prevent drug abuse. At rhe state level, there are
comparable laws as well as state drug cnforcemenr agencies
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cancer pain management and the meaning ami incidl!ncc of
addiction when opioids are used to manage pain. In 1997,
the PPSG (which conducted worlc.hop!> berwecn 1994 and
1998 w educate board member!. around the counrry nbout
pam management i!>!.ues) repeated the survey and found some
improvements in nttirudes of medical board members. Specifically:
• rcspondcnrs were more likd) in 1997 than in
1991 to recognize that opioids are undemtilizcd
as annlgesic<> for cancer pain;
• respondems in both survey~ ovl!n~!.tinwted the
incidence of addiction ro pain medications, bur
in 1997 fewer respondents confused addiction
with physical dependence; and
• medical board members in 199 Land 1997 \\ere
more skeptical abou t prescribing opioids for
noncanccr than for cancer pain, bur respondentS
in 1997 were more likely to consider prescribing opioids to patientS wirh chronic noncancer
pain for more than several months a::. acccprablc
medical practice. 1''
Since 1997 there have been a number of changes in the
legallandsc::~pe rc~arding the prescribing of opioids for pain.
Recently there has been an increased focus on undertreannenr
of pain, influenced in parr by the increased ::~ttention given ro
palliative ::~nd end-of-life care and the conrrover~y surrounding physician-as~i~rcd suicide. The American Society of Law,
Medicine & Ethics (ASLME), with support from rhc Mayday Fund,l 11 has addressed the issue of pain underm:anncnt
through a variety of educational initiatives and projects. In
1998, A~LME\ joint work with the Federation of Sratc
Medical Boards (fSMB) resulted in 1998 in the J\1odcl Guidelines for the Use of Controlled Substances for tht: Treatment
of Pain, rhus giving clear guidance to state medical hoard~
regarding opioid use for chronic pain. 21 The PPSG hao; been
rrackmg rhe adoption of the Model Guidelines as well as
orher state pain policies more generally for over a decade.
From 1989 to 200 I, there was a dramatic increase in the
number of new state pain policies adopted by stare boards
and legislatures. Many state boards have adopted policic~
that arc consistent with the FSM B's Model Guidelines (e.g.,
endorsement of a balance between preventing opioid misuse
and nor interfering with appropriate opioid prescribing; endor::.emenr of multidisciplinary collaboration in treating p:1in
patient..,~ inclu:.ion of treatment standards for chronic nonmalignant pain as we ll as standards for acute and
cancer-related pain).u HoweYer, there is no ltterarure indicating how state boards ::tre applying the guidelines and
Y\ herher they ::~re implementmg balanced policies for the
man::~gement of both m::~lignant and norunalignanr pain.
In addition ro the efforts of rhe ASLME, PPSG, and
FSMB, groups like Compassion in Dying have been trying ro
counter the chilling effect of sanctions for opioid pre::.cribing
by drawmg attention to cases in which pain was undertreated.

In 1999, the Oregon Medical Board was the first in rhc nation ro discipline a physician for failure ro pre cribe adequate
pain relief medication. The physician, Dr. Paul Bilder, was
cited for several pain undenrearmenr infractions, including
prescribing insufficient pain medication for a terminally ill
cancer patient (i.e., only Tylenol) and prescribing only a fraction of rhe dose of morphine that another patient needed and
the hospice nurse suggested. Dr. Bilder wa~ ordered by the
medical board to complete an educational program on physician-p::~ricnt commun ication and undergo mental health
rrearment. 11 In anorher case, in June 200 J, a California jury
awarded 1.5 million dollars to the survivi ng children of William Bergman, whose children sued their father's physician,
Dr. Wing Chin, for undertreating Mr. Bergman'~ cancer pain
before he died. Although the award was !>ub~equenrly reduced by the court, it was a dramatic message to physicians.
Moreover, in the same year, drug enforcement officials from
the DEA and twenty-one health organizations issued a joint
statement that they had begun to work together "to prevent
abuse of prescription pain medications while ensuring that
they remain available for patients in need. "14
Almost at the same time that we experienced this shift
in focus toward concern~ about underrreatment of pain, a
new risk surfaced that threatens rhe balance of providing
effective pain relief while minimizing abuse and diversion of
opioids- the abi.ISe of OxyContin. OxyConrin was approved
by the Food and Drug Administration in 1995. It has fewer
side-effectS than morphine but works similarly. It contains
oxycodone in a time-released formu lation that works over
12 hours, m::tking ir ideal for sufferers of both malignant and
nonmalignant chronic pain. However, abuse of the drug began when it was discovered that crushing the tablet and either
snorting ir or mixing it with water and injecting ir produced
a potenr high. Thus, OxyConrin has high addictive potential
for drug abusers and a high street value. According to the
DEA Office of Diversion Conrrol, from 1996 to 1999 the
number of drug abuse deaths reported to the Drug Abuse
Warning Network (DAWN) that involved oxycodone more
than quadrupled, with 268 deaths in J 999 compared to 5 I
in 1996. 25 Several cases were reported in the medi:1 stating
that physicians who prescribed OxyContin in relatively high
doses were disciplined by their stare medical boa rds. l~
SURVEY OF STATE M EDICAL B OARDS

In order to better understand how smte medical board!> are
balancing concerns about physicians underrreating pain with
concerns about phr::.icians overprescribing opioids, we undertook a nationwide survey of state medical boards. More
~pecifically, the sn1dy sought information regarding trends in
the number and nature of complaint!:> received by boards for
inappropriate prescribing of opioids (i.e., "overprescribing"
or "underprescribing"), how boards evaluate such complaints,
and under what circumstances bo::~rds would discipline phy-
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sicians falling into one of tho e categories. The focus of the
survey was board experience during the lastS years (19972001 ). The survey was conducted in Late 2001 and the first
half of 2002, just after the high visibility given ro the abuse of
OxyConrin in the press.

were more likely than nonrespondenrs to have implemented
an electronic prescription monitoring program that provides
access to a database of physicians' prescribing and pharmacistS' dispensing practices from pharmacies in the state. A
total of sixteen states have currently implemented a prescription monitoring program, all of which are electronic. 30
Thirteen of those sixteen states responded to the survey.

METHODS

As a first step, we developed a telephone survey tool basetl
on available literarure and input from experts in the field of
pain research and state medical board staff to identify state
medical board practices related to prescribing of opioids for
the treatment of pa.in.H Survey questions included the narure
of complaintS the board received over the previous 5 years
regarding opioid overprescribing and subsequent investigations of physicians and disciplinary action taken; the narure
of complaintS the board received regarding undertream1ent
of pain by a physician; the board's use of a pain management
expert in cases involving opioid prescribing; the likelihood
of the board raking disciplinary action against a physician for
underrreatment of pain; and the board's educational activities directed to physicians regarding treatment of patients
with pain. The srudy was approved by a University of Maryland institutional review board.
The survey was directed (by name) to the state board
medical director, or individual with a comparable title, and
that individual was asked to participate in the survey or to
provide the name of someone else in the agency who would
be most able to answer the survey questions. Of the fifty
stares and the District of Columbia, thirty-eight tate medical boards participated (a 74.5 percent r esponse rate).
Seventeen respondents were state medical board directors,
ten were chief investigators or prosecutors, and the remaining eleven included individuals with the following titles:
"medical director," "medical consultant," "program administrator," "senior complaint analyst," "chief [or 'director'l of
compliance," "consumer assistant," and "director of complaints and allegations." The respondents' average number
of years in their current position was 6.0 (standard deviation
= 5.7). Ten respondents were physicians, seven were lawyers, three were nurses, two were social workers, and several
had o ther advanced degrees (e.g., in business, public administration, and public health). Ten had worked in a similar
capacity before working in their current position. Thirtyfour respondents completed the survey by phone, and four
completed the survey in written form. u Qualitative commentS were transcribed directly from phone conversations
or from written commentS on faxed or mailed-in surveys.
Boards of those who responded differed in two significant respectS from those who did not. First, respondentS were
more likely not to have regulations, g uidelines, statutes, or
policies regarding opioid prescribing than nonrespondenrs.
lnrerestingly, all of the boards without such regulations, guidelines, statutes, or policies participated.29 Second, respondents

REsULTS

Opioid overprescribing: CompJaints
Respondents were asked to estimate the number of complaints31their board had received in 200 J related to opioid
overprescribing (i.e., "physicians who allegedly prescribed
opioids unnecessarily, in roo high a dose, or for too long a
duration")Y· An estimate was requested because most boards
do not formally categorize complaintS that relate specifically
to opioid overprescribing. J.l
1\venty-five respondentS were able to estimate the number of opioid overprescribing complaintS in 2001. According
to those estimates, the average number of complaints was
3.1 per 1,000 doctors in the state (standard deviation= 2.8,
range = 0 to 13.8).34 The most common sources of these
complaintS were pharmacies, government regulatory agencies such as the DBA, and family members of patients. Other
sources included physicians, law enforcement agents, or the
board itself (i.e., in the course of another investigation, the
board may have discovered cases of suspected opioid overprescribing). Some qualifying comments regarding the
number of complaints included: "some [complaints] run
together, for example, a complaint about sexual involvement may overlap with [a complaint abour] opioid
overprescribing," and "we do not track it that way, but my
sense is, it's extremely small. Out of 700 complaintS ... under a dozen rend to be related to [opioid overpre cribing,
mostly criminal referral]."
Eleven respondents were not able to estimate the number of opioid overprescribing complaintS their board received
in 2001 and shared comments such as: "we don't keep that
type of information .... [W]e categorize drug diversion, incompetence, negligence .... r really don 't know"; "I know
the number of complaints for inappropriate prescribing,
bur I don't know how many of those were for opioid overprescribing"; and "1 couldn't give a fair estimate, we have
codes within our rrackingsysrem, bur a lot of time the tracking code we put in isn't the same as the order to show cause
or the fmal adjudication." In this regard, one respondent
reported thar his board was "getting ready to add
undemearment of pain ro the [complaint form) as a specific
cause."
When respondents were asked their impression of
whether complaints against physicians for opioid overprescribing had increased, decreased, or stayed the same in the
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past 5 years, !>eventeen respo ndents (44 .5 percent) thought
com plain ts had stayed the -amc ("on average there's a relatively ftxed population of drug- ceking patientS and a relativel y
constant population of providers willing ro prescribe"), fo urteen (37 percenr) th ought they had increa ed, four (J 0.5
percent) thought th(!y had decreased, and three did nor know
( ee Thble I).

Another stated: "an electtonic database system would be ideal.
It work both ways: If a doctor wonder!> if he's the sixth doc
in the pathway, he can call the board and get t he answer in a
few minutes, and [vice versal."
Some respondents tho ught the abuse of OxyConrin had
made the public more aware of diversion issue ·, but had
"not increased [their] complaims or investigations." Others
made reference to OxyContin's being "the drug of the month"
("20 years ago it was Dilaudid, then Percocet, once upon a
time it wa · Demerol"; "OxyComin is a new problem, but
Lortab is mo re abused; there's still a diverse array of drug ";
"0 yConti n is just another drug in the mix"). One respondent commented: "we don't have issues with physicians
abusing OxyContin .... roJu r p ro blem has been with patients
elling o r diverting the OxyContin and physicians not tuni ng
in to thar." A few respondent , however, described !>erious
problems in their state with overdo e deaths from OxyContin,
o r o f people in their tate breaking into pharmacies and holding pharmacists up at gunpoin t, specifically reque ring
OxyContin ("we have seen a tremendous p roblem of crimina l theft o f OxyContin"). One respondent de cribed local
police and health care providers w ith an "otherwise unblemi hed record fo r 20 yea rs ... getting add icted to OxyConrin
.. . [and] stealing from patient." Others reported increased
prescriptions of OxyConrin, bur a one respondent commented : " that's not p roof of d iversion."

Drug diversion and abuse trends: OxyContin
Respondents were asked whether the problem of drug diversion and abuse in their state, in general, had improved, beco me
worse, or stayed the ame in the last 5 years. Eighteen (4 7
percent) thought it had become worse, eleven (29 percenr)
thought it had stayed rhe same, and five ( 13 percent) thought
it had improved. Four had no real impre sio n. Some commented that the drug d iver ion/abuse problem wa nor
necessaril y worse, but the board was do ing mo re ("raking a
little sterner approach rhan before 1996"; " pursuing it more
d iligently; we're more on top of it now"; and "we have more
ophisric.c'lted investigarory techniques, so we may just be mo re
awa re of what's goi ng o n"). Fifteen of the eighteen w ho
thought d rug diversion and abuse in thei r . tate had become
wo r e (83 percent) thought that the abuse and di versio n of
OxyContin had contributed to that trend, while the remaining three thought it had not. Some identified the problem!>
with OxyConti n as prompting newly enacted legislati on establishing a p rescription monitoring program in the state.
One respo ndent commented :

Investigations for overprescribing
When asked whether their board had changed its app roach
ro investigating physicians fo r opioid pre cribing in re ponse
to OxyContin abuse and d iversion, twenty-nine (76 percent)
aid no and five (13 percent) said yes. Four had no o pinion.
T hose who had nor changed their approach commented that
they conducted the ''same thorough investigation" of all valid
complaints. Others felt t heir investigative approach had not
changed, but their attention to the issue had increased. One
respondent identified drug diversion as a p1ioriry of the board,
which was working more with law enforcement to "stay o n
top of what' going o n. " Another respondent explained that

Any time you have a drug that has as much pre s
as [OxyConrinJ, it identifies weaknesses in :.ystems.
Then you have people who are more wil~ ng to look
for new ways to identify di version and abu e. This
might be one aspect that plays into the desire of
some to have this new drug mo ni toringsy rem ...
[to find] mechanisms to identify if a patient had
been to other physiciam, [looking for drugs to feed
an addi ction], o r indications of [Jrug J di versio n/
abuse, for peace of mind of the physician.
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the approach of their board included adapting to changes in
drug-seeking and diversion behaviors over the years:

increru.ed and decreased investigations over the pru.t 5 years.
One respondent shared his impression that "the board is
taking these cases more seriously than in the past ... [by]
cracking down on doctors who are overprescribing, and
wanting us to find information to back that up." Another
mentioned that physicians have clearer grounds for being investi~ted if they do notundersmnd the board's mles for the treaonent
of chronic pain and are practicing outside of their specialty
area. Others pointed to their board's changed attitude toward the treatment of chronic pain and how this has resulted
in fewer full investigations: "The board's arrin1de toward
prescribing opioids has changed. lf a docror can provide documentation showing that [s]he's following pain management
guidelines, the board doesn't pursue [itJ further."
Respondents were asked what factors would determine
whether their board \'I.'Ould fully investigate a physician for
overprescribing opioids.ll A "full investigation" was defined
as going beyond initial facrfinding (i.e., beyond merely sending a lener of inquiry to a physician or reviewing pharmacy
records). For example, one respondent explained that whenever his board received a complaint against a physician related
to opioid prescribing, the board conducted a preliminary
investigation during which it rypically requested a two-year
profile from the state pharmacy board to look at the general
prescribing practices of the physician. If rhey saw a pattern
of inappropriate prescribing or had received "a series of compbinrs over the years that poinr[ed] to there being a problem,"
this would trigger a full investigation. Six respondents stated
that their boards fully investigate all complaints related to
opioid overprescribing.
State pain guidelines, starures, regulations, or policies
were mentioned as providing guidance for when to proceed
with a full investigation of a physician for overprescribing.
All but six of rhe boards responding to the survey currently
have some form of guideline (si'<teen), statute (fifteen), regulation (twelve), or policy (nine) related to pain management. 36
For many boards, if a complaint was made against a physician who wac; found nor to be in compliance with the board's
pain rules/guidelines, rhis would trigger a full investigation
of that physician. Comments included: "if we don't have
good documentation, if it doesn't appear that the physician's
following the board's guidelines with respecr to prescribing
for pain, tl1en we'll investigate"; "for the most part we adhere to [our pain gujdelines] .... [we've made] a lot of progress
... teaching physicians how to do this appropriately. We ser
the minimum standard of care in any stare, documentation,
informed consent, proper referral, etc., so we look for that";
and "rhe general policy that was made known to ph ysician~
i!> that we leave prescribing and pain management control
issues to their professional judgment, but if there is a complaint, they better have proper documentation, such as
informed consent, history and physical, monitoring, etc."
Some respondenrs commented that the volume or
amount of opioids prescribed by a physician might trigger an

[fhe] physician's comminee of the medical society ... offers very consistent counsel; they've tightened their procedures over the years because the
screening tests we had in place for monitoring
[opioidsJ needed to be beefed up. They found loopholes like ... "beat-the-piss-test.com" websites,
[which led to requiring] all testing atone lab. We've
gone back and identified a lot of problems. It's
bener to nip it in the bud before it gets too out of
control.
Another respondent commented:
It's just a change in the marketplace we've taken
cognizance of. We just had a huge case of overprescribing where in the testimony it became apparent the number of patients looking for this kind of
prescriber. This particular doc had people coming from other states. That was his defense: "If
someone is in pain, you give them drugs." But the
board said, "Not necessarily. You comply with good
medical practice; you assess them and follow up
and keep records, etc. You don't just give them
drugs."
Respondents from other boards admined that finding the
right balance between identifying physicians who overprescribe opioids and those who are appropriately treating
chronic pain is not ::dways easy. As one respondent stated:
"[We're] still working on trying to figure out the appropriate
balance between pain management and overprescribing.
We're still looking at research ro find that balance."
When asked whether board investigations of physicians'
opioid prescribing practices had increased, decreased, or
stayed the same over the past 5 years (1997-2001 ), seventeen
respondents (44.5 percent) said the number of investigations
had stayed the same, fifteen (39.5 percent) said they had
increased, three (8 percent) said they had decreased, and
three did not know (see Table 1). Respondents were asked
why they thought the number of investigations had increased
or decreased. For those that answered increased, the most
commonly cited reasons were increased "public awareness ....
patients and families are more aware," and "people are more
inclined ro speak up than they have been in the past." Some
mentioned law enforcement actions ("there have been more
cases where there have been convictions [of physiciansl on
drug trafficking and selling lopioid] prescript:ions for money").
For those that answered decreased, one respondent cited
economic factors that limited the resources the board could
direct toward investigations. Changes in the board's arrin1de
roward opioid prescribing was mentioned as a reason for
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inve~tigarion - for example, if there were "large numbers of

Another commented:

patients receiving large number!> of opioids from the ~a me
individual who was seeing patients from a large geographic
region, that would rriggcr an investigation." Also, "if there were
extremdy large dosage. !prescribed], dur would make [the boi.trd]
question if the patient could safely consume that much.'' However, if there was evidence rhar backed up the need for the
amount of opioids prescribed, most boards would not in ve~
tigare further (e.g., ..if we determined that d1ey were providing
therapemic intervention , then we would close the investigation"). One respondent provided the following example:

[We're] looking nt complaint~ and poor charting,
[ca:.es where1the patient "lost the prescription"
and the docror write~ another, bur there\ no documentation of diagnosis or follow-up, etc. The
phy~ician 's probably gotten on lack of docu mentation- we can ' r prove fraud or diversion, bur
we can prove good medical practice standa rd~
were not [maintained].
Several references were made rousing judgment in e3ch

rf a person [has] had low back pain for the last 12
)Cars and has been raking long-term increa~ing
do~es of pain medicine over the year!>, and the
family is reporting it because [their family member is] an addict now, thar wou ld be investigated.
Any allegation that the pain is not sufficient to
warrant the prc~cribed opioid [would be investigated], so if it\ a cancer patient, no one will argue
with that.

ca~e:

You have to apply judgment; thi~ is not an area
that lends itself ro cookbook approaches. You have
to react to good intelligence, for example, a reliable source like a pharmacy or a.norher health care
provider-their threshold to report to the board
is high. We review DEA reportS for exce~., purchases monitOred, but pure volume doesn't necessa ril y indicate a problem. You have to tell whetha
it\ below standard of care, not jusr volume.

Another commented:

In addition ro rhe volume of opioids prescribed, the
credibility of rhe complai nt source, and whether there i~
documented compliance with the pain management <,tandard of ca re, board po licies or guidel ine'>. or state
regulations and statutes, boards look ar the egregiou!>ncc,s
of rhe physician·~ conduct. One instance of highly egregiou::. co ndu ct may be sufficient to warrant a full
investigation and subsequent discip line, wherea., with
milder forms of physician misconduct, a board may look
at the number of complaint::. and evaluate patterns of inappropriate prescribing or practice. The uniqueness of each
Gl'>c wa~ emphasized by man) respondents. Comments included: "each ca~e i., done on an ad hoc ba~i'>; ir depends
on who is repo rting, wh.u the allegations arc, how egregtotts [the physician\ conduct was], the past hi'>tory of the
doctor, etc.,. and "It's nor a simple answer; there\ no quota
sy~rem that a speci fie amount of drug means you're ri pe
for investigation. We're looking ,u .1number of aggravating factors."
In <,Ome scares, medical hoard invc.'>tigarors worked
closely with law enforcement, and thu!> looked closely at the
quality of evidence collected against a phy~ici ;ln (e.g., witness testimony qualiry, corroborating e\~dencc- for example,
if anyone observed the physician improperly prescribing opioid., - ho~piral records). One re'>pondcnr o;tatcd: "p.1rrnership
with bw enforcement is a very productive way to run an
investigation. They're more expert on the criminal.,ide, more
able to tdenrify witnesses - like people \\ ho get sex for
drugs don't want to testify, bur police have v. ays to find willing victims to come forward."

If we get a complaint that a doc's prescribing
Ox)rConrin 80 mg four times a day or three times
a day, ,- we'll ask the plurmacist if it'~ a cancer
patient. Sometimes the pharmacist doe~n 't know,
bur ... if they tell w. it's nor a cancer patient, it\
more than likely the doc will get investigated.
Numbers are certain ly an indicator, but they're
not the only indicator- ir's hard ro answer with
a straightforward answer. Every ca!)e ha:. a different rwisr to it.
In the absence of a board pain nunagement policy or
guideline, decision~ about investigating or disciplming a physician were often ba~ed on deviations from the recognized
standard of care. For example, a respondent from a stare chat
had contemplated but not yet adopted pain management guidelinesstated:
[An investigation is triggered byl the devianon from
an .1ccepted norm - if ~omeone is prescribing
differently from their peer~ in a specific spccialt).
As an example, the pain management people will
write I0 time~ the amount of opioids as others.
We wouldn 'r waste time with that person. Bur if a
physician's billing as an inrerni~r and prescribing
the -;a me as a pain management per<>on, we're going to go find our why. And if the pain management person i!> pre~crihing way above orhers, we'd
check that our roo. Deviations from a norm we
observe, bur we don't est.1bl ish the norm.
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Discipjjoe for overprescribing

-we move some of those through [a special program that is proactive rather than reactive].

When asked whether respondents thought the number of
physicians in their state who had been disciplined for overprescribing opioids had increased, decreased, or stayed the
same in the past 5 years, fifteen (39.5 percent) thought the
number had stayed the same, fourteen (37 percent) thought
it had increased, six ( 16 percent) thought it had decreased,
and three had no real impression (see Table I). Reasons
given by those who thought the number had increased
included an increase in numbers across the board ("our general numbers have increased" and "everything's gone up;
discipline for prescribing violations has not increased more
as [a] percentage of the total, we're clearing [backlogged cases]
more quickly, we streamlined our processes"); increased
awareness ("it has to do with increased public awareness,
increased awareness on our part; OxyConrin is more realized by all of us," and "there's generally a greater awareness
in the professional community and the public about this issue now"); an increased level of sophistication amoug drug
diverters/abusers ("people arc more sophisticated about getting drugs"); and increased scrutiny by the medical board ("I
think we're more aggressive in taking action because the
information is available to the doctors about proper prescribing practices"; " I would think it's ... increased due to
increased vigilance. Members of the board are on the lookout for that"; and "the board is paying more attention to
these issues, investigating them more seriously, that's my
impression").
Reasons given by those who thought the number of physicians disciplined for overprescribing had decreased over
the past 5 years involved the redefinition of "overprescribing." Respondents explained: "the board's attitude has
changed; now we have pain management guidelines and have
an established way of determining if a physician is deviating
from those guidelines. We're more aware of the need for
adequate pain management and how that should be documented"; "Because the quantity of opioids thought to be
appropriate has increased tremendously, those who used to
be disciplined now are not considered in violation. The upper limit has been raised, and we're okaying quantities now
Ithat are] four ro six times greate r than before"; and " I think
we were more restrictive than we are now. Now we recognize the necessity for pain management. ... [There's] increased
vigilance bur an acknowledgment that pain managemenr is
nccessory. We have a policy and pain management guidelines
now." Another respondent described a move by the board
toward a more proactive approach that averts the need for
disciplinary action:

Onere pondcnt identified being more proactive with opioid
prescribing issues as a goal that his board was moving toward: '']don't think the board has been looked at as being
proactive; they've been seen as more reactive, so we're trying to change that. [t's hard, though."
Respondents were asked whar facrors would determine
whether their board would discipline a physician for overprescribing opioids. Several respondents commented that each
case has a unique combination and presentation of facts,
making it difficult ro identify specific infractions that would
automatically lead to a physician's being disciplined- use
of individual judgment was necessary. Comments included:
"The board doesn't have any policies or procedures on this.
We wou ld look at it on a case-by-case basis"; and "We look
for records, testS, documentation, etc., and lthe board] make[s]
a decision about discipline. Our practices are very subjective." One respondent explained:
We rely on expert testimony. We would consider
the harm to rhe patient, whether the docror is boardcertified, how long the docror's been in practice,
whether there's been any prior discipline, or
whether [there's been] any fraud or financial exploitation, rhe severity of the problem, how long
it's been going on, which drugs were used, was a
patient harmed- ir wouldn't have robe more
than one patient, though typically ir is - and
whether or not rhe physician was impaired. [If the
latter, the physician would go to rehab and the
board] might nor discipline ... . The goal is protecting the public and rehab'ing physicians. You
don't always need discipline to achieve that.
There was generally les!> c;ubjectivity and inconc;istency in' olved in criminal diversion cases ("[The board is] pretty
consistent; we usually get a drug profile, get records, get
DEA or police ro investigate that, make a criminal arrest or
investigate, and get an emergency suspension for 90 days
....").
For many respondents, violation of a medical standard
of care was enough ro warrant disciplining a physician for
opioid overprescribing ("there's no need for a pattern or more
than one case. One act or omission fai ling to meet the guidelines or standard of care is enough if the facts are
corroborated," and ''the standard really is whether the physician is practicing below the standard of care and whether
there's a continued pattern of irregular or substandard care.
We usually don't have a problem with showing a pattern,
and if the phyc;ician is below the standard of care, we're
quick to bring action"). Others commented: "we'd discipline based on failure to meet generally acceptable standards

[W]e utilize other types of informal processes to
try to address a [physician] before a pattern of bad

practice is established .... [W)e identify (a physician who] ... needs further education but hasn't
established the [bad] pattern or egregious conduct
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One respondent ·rated: "We look to [our pain rule~ I to give
us guidance as to whether there's a violation. We rend ro
[apply] formal disciplinary action with doctor~ who have
~hown egregious conduct or established a poor pattern of
practice." Another commented:

of practice; usually it's based on poor recordkeeping, [rather
thanl'overprescribing opioids"'; "it's based on adherence to
medical standards of practice, and proof of that in documentation."
Respondents mentioned various things they looked for
when investigating phyc;icians for violating the standard of
care for overpre!>cribing opioids, including poor maintenance
of patienr record!Jpoor documentation, "upcoding third party
billing from a routine to a sick visit when Ithe visit is Iunder
five minutes - usuall y you don't even find a blood pressure
!charted !-significant findings of another disease entity not
being followed, like hypertension or hyperlipidemia, not
monitoring or following up," "red flags in the [patient! record
like lost meds ... . lllf we see a lot of that stuff, we starr to
think the doc doesn't know what he's doing. Especial!}
whether the doctor refers out or not fro a pain specialist]," 1s
"ongoing monitoring, discussion wirh the patient ... in general, an absence of appropriate doctunentation to substanti:ue
their professional decision." One respondent reflected on
how the pain m:magememsmndard of care hn chnnged:

We refer to our pain guidelines. It's not based just
on dose bur quantity. We realize that people arc in
pain and need medication for that, bur there come'>
a point where it's not physically possibl e to con sume so many opioicls in such a short period of
nme.
One respondent explained rhe benefits of referring to a posttion srntement when enforci ng opioid prescribing standards
for physicians:
We set up the position statement agaimt legal advice, because it cloesn 't have the same legal standing as a law or rule, but it allows us to articulate
the standard of care in each insrance. Expert testimony is then used when prosecuting a physician
to show that he did not follow the articulated standard. For example, the position statement says you
have ro sec the patient before prescribing drugs
for them. This rules out Internet prescribing. We've
gone after four docs for prescribing over the Internet
without seeing patients first, and we upheld th•lt
through the position statement. But the position
statement allow!> us to discriminate [aboutl when
to go after docs. We don't have to go after everybody .... The position ~tatement allows a physician to treat pain, that's standard of care, but it
doelt say that the physician need~ to com pi}' with
rhe minimum of appropriate medicnl practice.

What used ro be called overprescribing 5 years
ago is nor that now. There's been a change in the
field of pain management. Now we don't discipline for quantiry only. The thinking has changed
in the practice of medicine. Now we are focusing
basically on any practice that could be harmful ro
the patient, and this is based on standard of practice, which has changed.
However, a few respondents mentioned that ·tandard of
care violnrions would typically not be disciplined by their
board, at lca~t nor without a demonstrated pattern of infraction by a physician ("we have tO see a pattern"; "it would
have to rise to negligence on more than one occasion, or
innppropriate treatment; we'd have a hearing, there'd be due
process, it would have to be a pattern that was established";
and "obviously, any case where we see a pattern of patient
harm, willful and repeated violation of prescribing laws and
regulnrions, we'll discipline. Bur we'll probably try to educate the doc"). One respondenr stated:

The most common form of anction imposed in overprescribing cases was mt111darory education/retraining. Other
!>anctions included (listed in order of frequency mentioned):
license suspension, license revocation, probation, restriction
of opioid prescribing, monitoring of prescri bing practices,
mentoring and supervision, reprimand/censu re, and a fine.
One respondent srated:

It depends on all the facts, the pharmacy printout,
and we look at the pnrients - sometimes they
docror shop. But if it looks like the doctor wa
fully aware that the patient may have an abuse
problem and fsl he continued to prescribe, or was
asked by the board to take a prescribing course in
the past ... if after that rhe physician is still doing
the same kind of thing, we'll step up the disciplinary process.

We classify ou r drug problems tnro three categories: failure to follow [standards of medical practice], diverting drugs for self-u!>e, and diverting
drugs for money, sex, or other th ing~. We rake a
very different tack for all three. For the first, we
retrain. For the second, we rehab. For the third,
we have no patience.

Bo:ml!. that had adopted pain guidelines referred ro them
in making judgments about a particular physician's actions.

Orher comments included: "frhe sanction! depend!> on the
severity of the offense, frequency, contrition and recognition
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o n the part of the practitio ner, whether he's been before the
board on an offense"; "1 couldn't say, there's such a rangeeverything from revocation to public censure to nothing [to]
rehab"; "the sancti ons differ depending on the case"; and

circumstance as a real high threshold of some kind of neglige nce o r incompetence."). Othe rs demonstrated a
commitment to the issue, despite the absence of complaintS
("as a cancer survivor I' m sensitive to rhe issue, but I don 't
see complaints from cancer patients saying rhe doctor didn 'r
treat my pain carefull y" and " I've kind of looked for them,
but haven't found any so far. ").
A few respondentS gave examples of inadequate pain
management complaints as being revealed, through investigatio n, to be instances in which patients were actually
receiving adequate doses of opioids o r were addicted to opioids and then complaining that they were cut off from their
source of drugs. One respondent explained:

I don't always get the sanctions I want. [would
like tO see temporary suspension of a license and
mandatory attendance at an appropriate prescribing workshop. The sanction has to have enough
meaning to get their attention. Many can write a
$10,000 check and they don't miss it. ... You've
got to take them o ur of the loop a tittle while, get
their attenrio n big time.
Another respo ndenr explained:

We did have one doctor who was overprescribing
her patients who were addicted to narcotics, and
after we suspe nded her license, some of them
called to complain they couldn't get their med ,
bur those were [addicts trying to get narcotics, so
it's not a legitimate complaint of undertreatment
for pain].

If it's limited to a lack of knowledge, we have a
lot of cools to evaluate what to do.. .. [I]f it's a
pretty big problem, we end them to get a report
o n their skills/k nowledge .. .. [I]f it's a mino r
knowledge base [probJem], we send them to a
remediation program .... If there are other quality
of care issues, we send them to an evaluatio n progra m. Then with doctors trading drugs for sex,
that's a character problem; we wouJd invoke lo ngterm [license) suspensio n or revocation.

Twenty-seven respondents (71 percent) thought there had
been no change in the number of complaints the board had
received in the past 5 years regarding inadequate treatment
o f pain. Six respondents tho ught there had been more complaints, and rwo thought less. Three had no opinion. Those
who tho ught the number of complaints had increased attributed it to increased public awareness ("on a personal level I
find [awareness about this issue to have increased) in hospiraJs; my husband recendy bad surgery and they were constandy
asking him about pain- having him score his pain every
time you turned around'').

Opioid underprescribing: Complaints
Nineteen respondents (50 percent) were aware of complaints
to rheir board against physicians for undertrearrnenr or inadequate treannent of pain in 2001. Based on the thirty-three
respondents who were able to estimate the number of complaints, the average per 1,000 doctors in the State was 0.46
(standard deviation = 1.1, range = 0 to 5 .9). 19 The ma jor
ource of such complaints was patients (eight respondents
identified nonprisoners as the major source, two identified
p riso ners, a nd five reported both prisoners a nd
nonprisoners). 40 The other primary source of complaints was
family members (nine our of nineteen). One respondent explained: "!There arc] three major sections that prescribing
complaints can fall under: unprofessional conduct, incompetence, and fraud. Dnadequate pain management complaints
are] usually in the first two categories." Some felt this problem was underreported ("it's a very underreporred problem,
in my opinion"; and "I've had orrhopods proudJy say they've
never w ritten for a Schedule 11, and my quesrion is 'Why?
Aren't you dealing with people with severe pain ... ?' So I' m
sure there's undemeatment, we just don't see the formal
complaints."). A few respondents did not perceive
undercreatmem of pain ro warrant a serious response by the
board ("fwe've received] just a few [complaints about
undertreatmenrof pain]. Normally those were dismissed o r
no action was taken because the board doesn't perceive that

Investigations and discipline for underprescribing
Respondents were asked to estimate the number of investigatio ns their board had ever cond ucted related to pain
undertreatmenr. N ineteen respondentS thought their board
had never investigated a physician for undertreating a patient's
pain, and sixteen thought their board had. (Three did nor
know.) Of the latter sixteen, eleven were able to e~<imate the
number of investigations their board had ever cond ucted related to underrrearrnenr of pain. The average number of
investigations was 1. 7 (standard deviation = 3 .4, range = 0
to 13). Six r espo ndents said all the cases involved
nonprisoners, three said they involved only prisoners, and
three said borh prisoners and nonprisoners. Four did not
know. One respondent pointed our that physicians are not
required to "treat every patient who comes in rhc door," so a
physician may refuse to refill a new patient's request for
opioids- this is different from a physician failing to treat
people under his or her care. Only one board had acwally
disciplined a physician for undertreatment of pain.
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Respondents were given facts from the case regarding
Dr. Bilder, the physician who was disciplined by the Oregon
Medical Board for undcrtre:lting his p:~tie n ts' pain. Seventeen re!.pondent!> were familiar with the case, ten were nor,
and eleven were unsure. When asked how likel y the
respondent's board would be to rake disciplinary action again t
a physician for whom the board bad received similar compbints that were later corroborated, eleven re pondents
thought it was almost a certainty (i.e., greater than 90 percent), fourteen respondents thought it was probable (60-90
percent), three thought it possible (40-60 percent), two
thought it unlikel y ( 10-40 percent), and three gave other
ranges (between 60- 100 percent, and between 40-90 percent). Five could nor say.
Respondents' comments added further insight. Some
stared that their board is limited in the kind of disciplinary
action it can take ("the law only allows us to take disciplinary action if they're grossly negligent"; "we have to use clear
and convinci ng evidence ro prosecute, and that's a pretty
high ~tandard of evidence''). Several respondents commented
that each case is unique and ir would be difficult to predict
their board's response ("it depends on the facts" and "the
board tries nor ro make pronouncements on types of cases
because they're dependent on facts and circumstances. The
doctor may be making the right judgment in that particular
situation, it may be appropriate. There are no cookie-cutter
answers fo r these cases."). Some noted that more than one
instance of pain undertreatmem would be necessary ("you
can't establish a pattern of practice with one patient"). Others looked for level of egregiousness ("The decision would
be based on rhe medical record, and if there was a danger to
the health, welfare, and safety of the community, that would
definitel y be a legal basis for [disciplinary action]. If it was
found that the situation was egregious, there would be a
legal basis for a summary suspension.'').
A number of boards appeared disinclined ro consider a
standard of care violation alone as a basis of disciplinary
action in cases of pain undertrearmenr (''the board tends nor
ro discipl ine based on !.tandard of care but on [gross] negligence"). One respondent voiced frustration witb this general
tendency of rhe respondent's board:

intentionally make people suffer?"), implying that a physician'<>
lack of knowledge about adequate pain management would
be grounds ro evade board sanctions for pain underrrearmenr
("You would almost have to show criminal cruelty. [Giving
Tylenol for cancer pain, knowing it doesn't alleviate the pain,]
could show that."). However, a few thought their boards
would discipline if they could prove that rhe ~randard of care
had been violated ("yeio, standard of care would be disciplined, depending on rhe facts"; "we do discipline standard
of care issues; it's hard to prove somerimes, but we do •·; and
'·if the physictan is just disregarding the paricnr's complaint
[and the patient's] nor getting better, ::.tandard of care dictates
that a follow-up is required and, if [that does! not [happen],
then standard of care is not met").
Tho"e whose state medical boards had pai n management guideline!. or end-of-life legi!>lation used those guidelines,
policies, or legislation ro benchmark the phy!>ician's actions.
One respondent stated: "that\ just cruel ro those patients,
and ir\ nor in conjunction with rour] pain management guidelines." Anmher explained: "our state has pain rules that were
made by the board that the physician is expected to follow,
and if it was verified that rhe physician didn't follow them,
as would be the case with the physician in this scenario, that
physician would most likely be disciplined." Another commented:
A doctor would have ro ~how a pattern of practice
of undertrearment, and following our pain guidelines, if the patient's pain was 10 our of 10 and
[he's] giving Tylenol or ibuprofen, that's really ridiculous. Our consultants are in pain management
and they believe in treating for pain. [Bur] it's hard
to gauge '> ince we've never [disciplined fo r
underrrearment of pain] before. There arc eighteen different personalities on our board, and it's
hard to say how they'd go.
Yet another respondent stared:
In [this sratel you're not held criminally liable for
judicious ritration in cancer patients, so ro get an
undertreatmenr case, you just have to have a rea l
lack of education, and if we saw that, we'd have
to utilize some discretion. Why ditl it happen?
Can the physician be educated without sanction
and snll protect the public?

My problem here is we see standard of care [violation! cases all the time, but we don' t discipline
on [violation otl standard of care. For some reason
our reviewer .. . says, "well, it's not the best medical care, bur ir doesn't rise to the level of gross
negl1gence." I wo nder, what consrirutes gross
negligence? ... I don't think we do a good job at
all on standard of care. I'd like to think so, but we
don't.

Several re~pondenrs thought that, depending on the facts
of the case, a physician would likely be educated about pain
management before sterner o;anctions were invoked. One
respontlent!>tated: "they wouldn'tsuspend a docror's license
probably, they would probably want re-education. Some of
those programs here are very expell!.ive, but rhe board doesn't
let that srop them from recommending such a course." An-

Some respondents thought that the physician's intent would
be relevant ("was he trying to avoid DEA scrutiny rather than
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orher explained: "if it was an innocent mistake ... and if
there was no pattern .. . the remedial board would review
another 10-20 charts of that doctor, in a very collegial way,
and tell him what he needs to do, and [make it clear that]
'we don't wanr to sec you again."' One respondent wondered whether sanctioning a physician for underrreating pain
would lead to overprescribing problems ("once you discipline someone .. . they can go the other way. I've had
physicians say, 'Fine, I get disciplined for nor doing it, I'll
give everybody drugs. '"). One respondent thought," If you're
just coming in and spanking people, [that's not helpful] ...
doctOrs [needl good messages, roo .... Our goal isn't just to
discipline as much as we can." However, other respondents
thought their board was roo lenienr in dealing with physicians for undemearing pain.

certification in anesthesiology, twelve mentioned certification in pain management (mosdy through anesthesiology pain
management certification), seven mentioned experience-based
expertise (''usually it's a doctor who's well-respected in the
community and works for a pain clinic or runs a pain clinic"),
and one mentioned a combination of experience-based and
pain-management-credentialed experrisc. Six did nor know.
Sever:.tl mentioned that they try to march the specialty area of
the physician being investigated with rhat of the consultant
("If it's a family physician, we look for a family physician
who also trear.s chronic pain patients."). One explained: "very
few physicians are board-certified in pain managemem, [bur]
there are a lot who practice pain man:.tgemenr. We would get
an internist if an internist was involved, ere." Another reiterated: "few people are certified in pain management, though
most [experts] we use, that'<; their main specialty. They advertise rhemseh·es as pain managemenr experts. Most are
board-certified in their primary specialty at leasr. A handful
arc board-certified in pain management, but not a lor."

Use of pain management experts
Respondents were asked whether their board ever used a
pain management expert ro assist with an investigarion involving the prescribing of opioids (either underprescribing
or overprescribing). Thirty-one respondents said their board
had used such an expert. The mean percencage estimate of
cases 111 which a pai n management experrwas used wa!. 29.2
percent (standard deviation ::::: 35 .0, range from 0 to 100
pcrccnc).~ 1 This result must be interpreted cautiously, as so me
respondents qualified their answer by staring thar the denominator of rbeir estimate was investigations involving
opioid prescribing for pain management, nor opioid prescribing for criminal cases (e.g., physicians illegally prescribing
opioids in exchange for ex or money, or self-prescribing).
One respondenrexplained: "we have pain managemenrguidelines that we've published, and it's easy ro compare :.t
physician's behavio r ro those guidelines, but I'd say we refer
to a pain manage ment expert in about 20 percent of the
investigations, bur they [also] use our guidelines." Another
stated: "in a case right now we're using a pain management
expert, bm that's only the second or third time. Usually the
ca~es are pretty clear." Some respondents stated that their
boards use a pain management expert whenever disciplining
a physician for opioid prescribing practices, or whenever the
board has a hearing in which someone te~tifies agaim.t rhe
physician for issues related to opioid pre:-.cribing. One respondent explained: "if the nex us of the case is pain
management, then a pain management experr is involved."
One respondent noted rhat recent legislation required that a
palliative care physician sir on the board. Another stared:
"with our budget problems, [we don't use a pain management expert! as often as we'd like ([only] about 20-25 percent
[of the rime]). [There's] a pretty good mix o f physician~ on
the board and subcommittee. They usually do okay, but sometimes rhey need the expert."
When asked to name the credentials of the pain management expert used, five respondents menrioned board

Potential chilling effect
Several respondents commented about the potential chilling
effect that could be created by the board's investigations of
and disciplinary actions against physicians for opioid prescribing. Some wondered how these fears were propagated.
One commented: "the thing that surprises me is that physicians won't prescribe because they say they will get in trouble
from rhe state. Where do they get this idea? ... It's always
baffled me where they get that from. Urban myth." Another
srated: "there's a perception by many GPs or internists that
we are something much bigger than we really are. It's the Big
Brother syndrome, like the IRS, a bigger perception rhan
man} of us in the regulatory business are really aware of."
Others thought there might be some truth to such concerns,
as is conveyed in the following comment:
It has gotten out that the board is very active and
this has created the feeling of some in the medical
community that we're out to get them. And some
have asked me ifl'm worried that we're being roo
aggressive, and I do worry about thar. Bur 1worry
roo that they'll forger we're here.
Anorher responded similarly, emphasizing that the interest
in avoiding a chilling effect must be balanced with the board's
obligation to protect patients from harm:
Doctors like to cry foul anytime we inquire about
anything, and say we've scared them so they're
no t going to prescnbc anything. lr's just a problem
we h:.tve to deal with on a case-by-case basis. There
are doctors o ut there who arc harming their patients, and we have ro protect rhe patients too.
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Board-sponsored education/trainillg

Fourteen respondents reported that rheir board had provided educational sessions on the treatmen t of patients
with pain. Some were talks and presentation!. abou t pain
management given at hospital<> or other venues. O nerespondent reported: "IWe'vel sent sraff out ro give presentations
and have been keeping track of those since 1999. I ha ve a
li:.t five page long of all the places we've gone: 137 presenratiom since 1998, 38 jwercl pa in ma nageme nt
speeches, and 25 !were I overviews with pain management
references as parr of the conten t." Another sr~1ted : "the executive director has spoken on this .... We try to be as
proacti ve as we can." Others mentioned full- or half-day
seminars or training sessions provided by the board on
pain management and proper prescribing- some were
one-rime sessio ns and others were given an nuall y or more
often. One respondent referred to a recently passed bw requiring physicians in the state to take" 12 hours of CME
[conti nuing medical education Jon end-of-life care and pain
management" as a possible solution to rhe problem that "a
lor of people our there are nor bei11g treated appropriately for
their pain, and doctors don't recognize thar. ., Another board
was "also looking at mandatory CME in pain management
for physicians."
Of the twenty-four respondents whose boards did nor
provide educational sessions on pain management, comments
included: "this is being discussed, [bur it's I available in the
private sector"; "we're talking about providing CME on pain
management and end-of-life hospice issues, bur ... nothing
has been finalized" ; "we defer to Purdue and other workshops"; and ''I wish we had rhc sraff; however, there are
real.ly terrific people purring CME sem inars on in the community that are excellent. There's a wealth of resources in
rhis area, so there's no excuse for nor having knowledge
about pain management."

Twenty-eight respondents stated that their bo::~rd had distributed educational materials regarding treatment of patients
with pain. In most cases, these were arricles in newsletters
or publication of the board' pain man::~gemcnr guidelines or
rules. Others mentioned distributing press releases, white
papers, and pamphlet on the ~ubject. M::~ny of the bo::~rd s
provided the same information on their website. One re:-pondenr sratcd rhar "our position statement on pain
managemem is given ro physicians when they're licensed,
and they're interviewed by a board member to reinforce their
knowledge of [the position statement]." Others covered appropriate prescribing for pain in mandatory orientation
sessions for new physician licensees. In o ne stare, "any new
physician who applies has to take a written test based on all
rhe board's rules, [including appropriate opioid prescribing]."
Several respondents emphasized that the focus of these educarional efforts was on proper documentation and follow-up
of patients treated for pain, particularl y for chronic pain,
e.g., ''The [emphasis.I thar our board has [stressed wirh.J physicians is documenting their treatment plan, diagnosis, and
rationale for what [they're] prescribing. That's where physicians will get into trouble. It's necessary for the patient and
good for the doctor; for example, if the patient needs ro
change physician , those records speak volumes"; and "We
sent ro phy'iicians [in rhe state! ... a letter saying basicall y
'we don'rwant you to overtreat or undcrrreat [your] patients'
pain, and if you ever have a complaint with us, this is what
you need ro hnvc in yourfile, and if you don't have it, you'll
probably be in trouble with us." One respondent questioned
whether physicians were "getting the message":
!Thi:. state I has specific legislation in this practice
!chronic pain managementI and how it's supposed
to be done. We have shared tharwirh physicians in
our newsletter, and we give talks, but rhe word
doc&n't seem to get our. Physicians who we find
are overprescribing complain that "the board's
picking on me," bur we're nor. It's an issue of
good medica l practice.

Balancing the need for appropriate treatment with
preventing abuse and diversion
A few respondents thought rhat physicians might be hesitant to prescribe opioids to terminally ill patients ou r of
fenr that they might hasten rhe patient's death. One respondent said rhar the allegations made to rhe board rel.ning
ro underrreatmenr of pain typically involved "a fundamental value system" in which physician), "have very strong
feel ings about nor wanting to hasten a patient's death." Tn
such cases, the board "trie!sl to ass ure phy<;icia ns that it's
within accepted practice to palliate at the end of li fe and
this is not seen as eu thanasia or physician-assisted suicide, but often physicians really struggle with rhar issue."
Most respondents, however, fel t that pain management ar
the end o f life had seen the most improvc.:menr as fa r as
boards being better able to distinguish adeqnare opioid
prescribing from ove rprescribing, as is evident in rhe following comment:

Another expressed frustrati on with the limitations o f whar
could be accompUshed by a nonauronomous board:
My board .... can'tdo a lor of things because [we' re]
under an umbrella agency that administers our
budget and other things. We can complain but are
limited in what we can do .... such as writing/
distributing educatioml brochures and all kind s
of creative things .... I work wirh "inside the box"
type people, which you see in government agencic.:s a lot. Creativity and innovation arc nor encouraged, and when you achieve them, you' ve had
tO fighr hard. Everything is a struggle.
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The board's in a rough spot. As soon as it goes
after someone for overprescribing, the first reaction is "that's chilling treatment for pain." They
duck for cover under that. Bur those cases are
apples and oranges. Those who are diverting apiaids take cash only, they deal with patientS who
have a criminal history, they don't keep records.
There's no comparison to, for example, treating a
dying cancer patient. Complete apples and oranges.
It's not like someone in hospice, dealing with a
patient who needs pain medications. Our board
has a position statement on end of l.ife that covers
all this.

good." Underprescribing is still an issue, but there's
also the issue of people being so overprescribed
-we bad one woman who was a school bus driver
and she couldn't even move [because she was so
drowsy from the prun medication].
The following respondent's comment concerns the same issue - how to balance treating valid chronic pain with
protection against abuse of opioids:
Chronic pain in my opinion is a subspecialty. Even
expertS don't agree [on] what to do. The problem
1 have is not so much with the pain specialises, but
at rhe ... level of general practitioners and internists who end up with patients with chronic pain.
Sometimes they do a good job at handling it, sometimes theydon'r. A lot of these doctors don't know
how to say no to patients, they don't really understand whar's going on. They can get into trouble if
they take everything a patient says at face value.
How do you know if I really have a migraine? ...
It'-; hard. No doctor really wants to bother with
the chronic pain issues. I knew a pain management specialist who said it took 3 months for her
to get a feel for whether certain chronic pain patients were lying to get meds. Everyone lies. We've
had physicians lie who are under investigation,
and if physicians lie, you can bet patients lie.

Some respondents commented on the difficulty in reconciLing the changing atrin1des and practice standards in pain
management of reccnr years with the ongoing problem of
drug abuse and diversion. One stated: "it's a real challenge,
finding that balance betw·ecn under- and overtreating pain."
One pointed to the difficulty of managing pain in the fragile
elderly: "what might be an appropriate dose for a young person is not for an elderly frail person who's on multiple
medications." For some respondents, their job was easier
when there was a clearly established upper limit for prescribing opioids, as the following comments demonstrate:
[There's been a] tremendous change in the management of chronjc pain and the attitude that there
doesn't seem to be any upper limit on opioids.
The attitude now is "whatever works." 1have problems with that because ['m faced with figuring out
whether opioids are being diverted or not, and I
have suspicions that a lor of patients are conning a
lot of doctors into giving them meds and don't get
questioned because of this "whatever works" attitude. We will have to figure out how to counter
that .... We used to sanction based on the PDR
[Physicians' Desk Reference] limit (like 40 mg a
day for oxycodone), but now that's almost never
the basis of OLlr sanctions. Patients are on 700 to
800 mg of oxycodone a day.

One respondenr agreed that many physicians prefer not to
treat patientS with chronic pain, and that it is better for them
to refer such patientS to a pain specialist:
Some chronic pain patients are tough to treat and
some doctors feel they don't have the time rospend
with those patients. One of the things I always say
is don't dabble in pain medicine. Do it right, for
the sake of the patient and the doctor. It's better to
refer [patienrs to a pain specialist] than to do it
haJf way.
Yer, another respondent identified the problem of the lack of
access to qualjry chronic pain treatment in pain clinics and
centers:

The numbers we're seeing, the doses are kind of
unreal at rimes. You have a physician who's not
educated in pain management, and this mjght sound
bad, but there is this rhetoric aboutservingchronic
pain patients, so physicians tend ro do it. Some
have good hearts and don't know how to do it
well; some don't have the heart but see it as a way
to have a practice. But they're not following good
medical practice in prescribing, they're just prescribing. They don't have consults, they don't document about what's going on- sometimes it's not
even based on good pharmacology, just "oh, this is

One of the problems is that the pain clinics arc
undersupporred, they're short of doctors willing
to practice pain medicine/anesthesiology, they can't
get paid. [This causes a] population of people to
seek out individual physicians, some ofwhom lack
the skill set to treat this type of patient. It's a difficult problem. One psychiatrist opened a pain
clinic, no prescribing experience before. He's gone
from none to the top three OxyContin prescribers
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ary actions. That is, if the number of opioid overprescribing
complaints was perceived to have increased in a jurisdiction,
the number of investigations and discip linary actions either increased or stayed the same. Likewise, if the number
of compbints stayed rhe same or decreased, rhe number
of investigations and discipli nary actions either stayed the
same or decreased. These results were based on perceptions
(rather than actual numbers), as it is still the case that most
rate~ lack systems that track complaints based on opioid
prescribing.
We questioned whether rhe presence of a state prescription monitoring program might have had nn influence on the
number of complaints or investigations related ro opioid prescribing. Compared to respondents from states without an
electronic prescription monitoring program, we found that
respondents from states with such a program were genernlly
more likely to think the numbers of complaints, investigations, and disciplinary actions against physicians related to
opioid prescribing had stayed the same over the pasr 5 years
rather than increased or decreased (see Table 2). Regarding
estimates of thl! number of opioid overprescribing and
underprescribing complaints received in 2001, there were
no statistically significant differences betw·een boards with
and bonrds without an electron ic prescription monitOring
program. Thus, based on respondents' estimates and perceptions, it docs not appea r that electronic data tracking
mechanisms led to increased numbers of complaints, investigations, or disciplinary actions against physicians reb ted ro
opioid overprescribing practices.
While nearly rwo-rhirds of respondents reporred rhat
opioid overprescribing complaints had decreased or srayed
the same, over a third of respondents perceived thnr opioid
overprescribing complaints had increased in their jurisdiction during the past 5 years. This appeared tied to a perception
that drug diversion, in general, had been increasing. A significant number of respondents believed that drug diversion
on the whole was worse in their state than it was 5 years ago,
although some attributed this ro more diligent efforts w seek
our such diversion. Of the eighteen respondents who thought
drug diversion had worsened in their state, fifteen thought
that OxyConrin had significantly contributed ro this problem. On rl1e other hand, of the thirty-three respondents who
had an opinion on this issue, fourteen (42 percent) did nor
think OxyContin was a problem in their state. This is likely
due to the variation in abuse patterns of OxyContin across
the nation. A large majority of respondents stared that their
board had not changed its investigative approach in light of
OxyConrin concerns, but the overall tone of their comments
regn.rcljng drug diver ion indicated rhnt, in general, their boards
had taken more active steps to address this problem.
As regards decisions ro investigate physicians for overprescribing, it appears thara number of boards are arrempring
ro find the appropriate balance between identifying physicians who overprescribe and rhose who are appropriately

in the state. So, how does thar happen? With virrually no records kept. People are walking in with
money.
Another agreed:
It's the standard of care tu take care of people's
pain just like it's the standard of care not to be
duped. That shows how colossally difficult the
board's job is here. When do you cross over from
appropriately treating pain to hurting patient!)? [
think people get into trouble with tlli.s because it's
easy money for doctors. l think the brass ring is a
pain center connected with an academic center,
where they're well-trained, well-managed, look
at all problems, not just pain. Patients who are
marginal and might be abusers are put on contracts and rhey have ways to keep them from participating in diversional activity ... . I'm always
impressed with these pain centers ... they make it
undesirable for drug-seeking individuals to [use
their services.]
Several respondents commented further about the diffi culty boards have distinguishing valid chronic pain from
drug-seeking behavior. One srated: "With the advent of new
end-of-life legislation ... physicians ... feel freer to go ahead
and prescribe the pain medications that are needed. This
helps a lot. Regarding chronic pain, physicians arc much
more cautiou~ about that." Another acknowledged:
Ir's easy if the pntiem is terminal. It's not so easy
with intractable pain. Is rhis a drug-seeking pariem or a patient with valid intractable pain? That's
a difficult call for physicians and a difficult call
for us. Maybe with rime there will be more sophisticated diagnostic tools available w make it
easlCr.
DISCUSSION

Our study results indicate significant variation among state
medical boards regarding experience with and reaction to
overprescribing and underprescribing opioids for pain treatment. With respect to overprescribing, states were divided
on their perceptions of whether the number of complai nts,
investigations, and disciplinary actions for opioid overprescribing over the past 5 years had increased, decreased, or
stayed the same. The largest group, in each case, indicated
they thought the numbers had stayed the same. A slightly
smnller, bur significanr, group thought they had increased,
and only a few believed they had decreased. However, it
appea rs from the data that there was consistency in responses
regarding trends in complaints, investigations, and di5cipl.in-
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treating patients with chronic pain. A number referred to the
fact that their board had developed a policy or guidelines for
prescribing for ch ronic pain that were a significant aid to
rhem in deciding whether ro investigate or discipline a physician. The number of boards that have adopted pain management
guidelines, regulations, or policies has, in fact, increased over
the last 4 years, with boards specifically addressing the issue of
chronic no nmalignant (o r "intractable") pain. In 2001, the
PPSG documented a total of eighty-two state pain policies in
the form of stawtes, regulations, guidelines, o r policy statements. As of 2001, twelve states had adopted the FSMB's
Mod el Guideli nes in full, and nine in partY
It is unclear to what degree the existence o f such policies correlates with a board 's commitment to educati11g
physicians about pain management and o pioid prescribing
issues (i.e., to mitigate the chilling effect that has caused
physicians to avoid prescribing opioids when they are needed
to treat pain). Although the fi ndings reported here must be
i.nterpreted cautiously, it appears that boards with state pain
policies that address the treatment of chronic, nonmalignant
pain are mo re proactive, in that these boards provide mo re
pain-management-related education to physicians than boards
that do nor have such policies (see Table 3). H owever, we do

not know w hether the content of such educational efforts
strives to balance education about overprescribing with that
of pain w1dertreatment concerns. More research is needed
to determine what speci.fic messages boards are sending to
physicians in these educational efforts, how physicians are
interpreting these messages, and how such educational efforts are affecting physicians' opioid prescribing practices.
Respondenrs' commenrs indicate that boards are focusing on making their pain policies known to p hysicians so
that physicians are aware of what is required of them to
avoid scrutiny b y the board. A number of boards emphasized w hat should be present in the patient's chart to avoid
suspicion by the board that the p hysician is overprescribing
(e.g., patient assessment, pain diagnosis, plan of care, evaluation, follow-up, specialist referral) . These efforts serve to
reassure physicians that they will not be disciplined for overprescribing opio ids ro patients with chronic pain if they
confo rm to standards of p ractice and state pai n policies. On
the other hand, if a physician is accused of overprescribing
and lacks proper documentation of his or her practices, he
or she is much more likely to be investigated and disciplined.
Al1 encouraging result for pain managemenr advocates
is that boar ds appear to be moving away from vol ume or
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overprescribing op.ioids, most respondents stated that it was
a matter of judgment, t hat it was very fact specific, and often
subjective. However, for those that had established pain
management policies or guidelines, these appeared key in
determi ni ng whether to discipline. Significant departures
from the policies, in some cases, could be a basis for discipline. Boards varied regarding whether they would require a
pattern or more than one instance of overprescribing before
disciplining. Poor documentation and recordkeepi ng were
also consistentl y cited as key factors in disciplining physician in the e cases. A number of boards also mentioned
using pain experts to assist them in deciding whether to discipline in cases of overprescribing. A lack of availabiury of
credentialed pain experts may interfere with some boards
getting the professional guidance they need to investigate
physicians for opioid prescribing practices.
Over half of the respondents (55 percent) th ought the
number of board disciplinary actions relating to opioid prescribing practices had either stayed the same or decreased
over the past 5 years. Respondents who observed a decrease
offered reasons that were encouraging for advocates of better
pain management. These board repre enratives thought their
board's attitude toward opioid prescribing had changed over
rhe past 5 years and that their pain management gu idelines
helped them in a number of cases determine that the prescribing practices of rhe doctor under investigation were

quantity of opioids as a primary basis for investigating a physician for overprescribing opioids. Some respondents referred
ro volume as a trigger but not conclusive evidence for a deci~i on to investigate. Many respondents indicated that these
were very fact-specific cases that had to be evaluated individually; that all facts, including the diagnosis of the patient,
the documentation of the prescriptions ordered, and consistency with established guidelines, had to be considered.
Despite this positive trend away from using volume a a determinative factor in moving f01·ward to investigate or
discipline, a few respondent comments were troublesome in
that they implied a continued reliance on volume and, in at
least one case, a lack of knowledge regarding issue of dosage and volume. For example, the comment, "It's nor based
just on dose bur quantity .... there comes a point where it'
nor physically possible ro consume so many opioids in such
a short period of time," might be accu rate if referring to an
opioid-na'lve patient. However, it is possible that a patient
with intractable pain might be adm inistered large doses of
opioids wirh a sharp dose escalation (i.e., large doses in a
sho rr period of time) in order to obtain pain rel iefY Thus,
misunderstandings still . eem to exist about opioid vol ume
and quantity upper limit<> (i.e., that the latter exists independently of case-specific facts, which is generally not the case).
In response to the question regarding factors that the
board would consider in deciding whether ro disci pline for

T \II I.E 3.

Ent ( . HE Pm Sit ., \\S \Bot I p \I"\ \I\:\ \(,1· \II· ' I
'Bo\lm Poun Anmu.ssl:\<; CIIR0"\1<", No"\\1 \J.((;"\" 1 P \I"\.

DIFFimENCES 1:--; EFFORTS TO
ExiSTENCE OF

PAJN MANAGEMENT Enuo m oN!

T!wNING nv BoARD*

Pain management content in
newsletter
Wriuen pain management materials
avai lable/sent to MDs***

BoARDS WITH CHRONIC, NONMALIGNANT
PAIN Poucr** (Tl

=30)

54%

( 15 of28)
4()0;b

(12 of 30: II sent to MDs)

n \SJ-.1) ():\ ., m:

BOARDS \VJTHOUJ' CHRONIC,
NONMALIGNANT P AIN P OLICY** (n

=8)

17%
( I of6)
14%
(I of 7; I sent to MDs)

Pain management content in
orienunion

14%
(4of28)

0%

Pain management ses~ ion s
given by board

47%
( 14of30)

12.5%
(I of8)

-

Po/icie1 wldres.1inJ1 d1ronh·. nOIIIIIIIiiJ~ tUJIII pain werr idewijied based on tile t·ategori: ation uf policie~ li~·ted on 1/w Pain & Policy STudies Group
wcb1i11t. See Puil1 & Policy Studie.1 Group. UniversiTy of Wisconsin Comprehensire Cancer Cem er, Data-base of State Laws, Regulations. and Other
Oflici~l Government Policies. at <http:/lwll·w.med.rch.wi\·t·.edu/painpolicylmatrix.lmn> (last updmed November 5. 2002).
'~'Rc.,pmuit•l!t\ were ct.1kt'd: Hll.l wmr hoard distrilmtnl tillY edtll·mioHal material~ regarding Treatment of pmiellls 11·ith pain (e.g.. copy of guidelines.
nett ~leuer.1, brod111re.\, t•itletH)? Ha., your board held tilly educationol sessiom 1m treatment vf patients wiTh pain? Does the board tJrot•ide any
additional CIISiltWiet' to 1•hy.licitl11S .reekiHg guidcmce .for tile tr.:mme/11 tifpatients with paiu? If responde/lis a11swered affirmatively. they were a.1ked
10 de~ui/1e thl' Tl'/11'.\ of nwteria/.1. seS.I'ion .~. or additional anistance. lnformatiOII here is based 011 a content wwlysis of respol!dents " commenTs.
Perct•mnge.l art• t•alitl tow/~. Mi.1si11g dow art• tile result of n•sponde11ts 11'1111 1"0111pleted (t ll"rillc'll ,111rvey. cmsll'ered ··yes·· to ony of the questimu. hm
did 11(1/ provide qualttwn•e elabomtion.
**Tin·.1e an• .\Ill/lite.\, n•gulatio11.1, guit!t>liue.l. or policies then oddreH treatmem of or opioid prescril>illf! for duouic. 11onmalig11al11 poi11.
•**Thew- includi•d paiii-IIICIIIIIJil'lllf!lll·rt'imetl /Jroc/1/lre.\·. topie.s t({ pain pl)/icies, position statements. and the like thm were al'flilable upon request
wul/or diHrilmted to physicians (e.g., b)' mnil or other metlwds n.f distribution).

37

Volume 31:1, Spring 2003

reasonable, where prior to the adoption of the guidelines
they might have disciplined the physician.
The number of estimated complaints boards received
for undetprescribing were significantly fewer than those received for overprescribing (in 2001, an average of 0.46 versus
3.13 complaints, respectively, per 1,000 doctors in the state).
A significant majority saw no change in the number of complaints received for underprescribing over the past 5 years.
While some respondents thought the problem of pain
underrreatmenr was real and merely underreported, others
did not seem to view undertrearing pain (particularly chronic,
nonmalignant pain) as a significant problem.
While nor equivalent to complaints received for overprescribing, it appears cl1ar the number of complai nts for
underprescribing has increased. Martino cond ucted interviews with medical board executives between November
1997 and January 1998.44 At that time, only one board (California) of the thirry-six surveyed had received a complaint or
report explicitly alleging undertreatment of chronic pain.
Several had received complaints from prison inmates alleging that certain medications had been denied as a form of
punishment, but they generally were not pursued as pain
underrreatmenr cases.
As regards disciplinary action for undertreating, many
boards appear disinclined to discipline simply for v.iolation
of standard of care, which is how many respondents depicted cases of underprescribing pain medication. They would
be more Likely to recommend education to the physicians in
such cases. This appeared somewhat at odds with the responses given to questions about disciplining for
overprescribing, where respondents said they were more likely
to discipline for violation of standard of care, even without a
pattern of poor practice. Thus, there is a lack of parity in
application of standard of care and patient harm as bases for
discipline in cases of undertreatment versus overrreatment.
Overprescribing is more often seen as a clear violation of
standard o£ care and a clear example of patient harm, whi le
many respondents, or their boards, do nor view
underrreatment, particularly for chronic pain, in the same
way. They appear to apply a higher threshold of harm for
undertreating pain.
A nurnber of respondents, however, did provide examples
of cases they thought could be construed as gross negligence
or egregious behavior regarding pain undertreaanenr and said
that such ca es might lead to disciplinary action. Consistent
with this response, a significant majority of respondents (79
percent) said that if they were presented wicl1 a case where
the facts were similar to those of Dr. Bilder (the physician
who was disciplined for underprescribing by the Oregon
Medical Board), it was either highly likely or probable that
they would discipline rhe physician.
In regard to the potential chilling effect of the board's
efforts to oversee opioid prescribing practices, some respondents showed concern mat physicians might "go the other

way" (i.e., overprescribe opioids if disciplined for undertreating
pain, and vice versa). Some boards were working diligently
to ease physicians' fears that they would be investigated or
disciplined by the board for prescribing opioids to patients.
Several thought such fears were completely unfounded or
perhaps a convenient excuse to avoid the added work involved in treating chronic pain patients. Others realized that
the board's actions had a chilling potential, but thought there
was little tl1ey could do, that it was the physician's faul t for
jumping to false conclusions, and that such is the price that
is paid for protecting patients. These respondents were aware
of the problem of inadequate pain management, but seemed
to give more weight to concerns about overprescribing.
Respondents spoke of"prorecting patients from harm," yet
did nor view opioid overprescribing and pain undertreatmem
equally in the degree of public protection rney demanded.
This type of attitude may contribute to a shortage of physicians who are able and willing to treat patients who have
chronic pain. While advocacy for pain management on the
part of many state boards may ease physicians' fea rs about
being disciplined for opioid overprescribing, many physicians may decide that their safest (or least burdensome)
course is to refer patients with chronic pain to a pain specialist. With the number of patients suffering from chronic
pain greatly outnu mbering the number of qualified pain specialists, the results do not add up in favor of those with
chronic pain.

CoNCLUSION

In sum, we cautiously conclude from out survey results that
the attimdes and practices of medical boards toward physicians' prescribing of opioids have changed for the berrer over
the last several years. Respondents' references to the need
for "balance" between ensuring appropriate treatmenr of pain
and disciplining physicians who are inappropriately prescribing opioids are illustrar.ive of this movement. The work of a
number of individuals and agencies, including the Wisconsin Pain & Policy Studies Group, the American Society of
Law, Medicine & Ethics, the Federation of State MedicaJ
Boards, through its Model Guidelines, and the recent DEA
joint statement, has reinforced this message of the need for
baJance and may have played a role in moving boards forward on this learning curve. Moreover, boards' abandonment
of opioid quantity as a marker of questionable practice, in
favor of an individual assessment of w hether the physician
has appropriately evaluated cl1e patient, prescribed consistent with board guidelines, and appropriately documented
his or her prescribing, further indicates progress in board
recognition of the need for adequate pain rreatmenr.
At the same time, some attitudes and practices by boards
remain problematic- in particular, a continued tolerance
of undertreatment. While many boards are becoming more
proactive in educating physicians about pain management
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